{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:05:49Z","timestamp":1790805949640,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Inflammation is a key driver of diabetic kidney disease (DKD) progression, with the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome representing a promising therapeutic target. Soluble epoxide hydrolase (sEH), an enzyme that inactivates renoprotective epoxyeicosatrienoic acids into less active diols, has been implicated in renal pathophysiology. This study investigated the role of sEH in renal tubular NLRP3 inflammasome activation and its underlying mechanisms in DKD. We observed upregulated sEH expression in high glucose (HG)-stimulated human proximal tubular epithelial (HK-2) cells and diabetic kidneys. Pharmacological inhibition of sEH attenuated diabetes-induced mitochondrial damage, mitochondrial reactive oxygen species (mtROS) production, NLRP3 inflammasome activation, and renal dysfunction both\n                    <jats:italic>in vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vitro<\/jats:italic>\n                    . Furthermore, sEH inhibition restored autophagy flux and enhanced PINK1\/Parkin mediated-mitophagy. Activation of mitophagy by the autophagy inducer rapamycin (Rapa) alleviated HG-induced mitochondrial impairment, mtROS overproduction, and NLRP3 inflammasome activation in HK-2 cells, suggesting that the anti-inflammatory effect of sEH inhibition is mediated through mitophagy regulation. Further mechanistic studies indicated that sEH inhibition promotes mitophagy, thereby improving mitochondrial function, reducing mtROS generation, and subsequently suppressing mtROS-dependent NLRP3 inflammasome activation in DKD. In conclusion, our findings establish a novel link between sEH and NLRP3 inflammasome activation in DKD pathogenesis, highlighting sEH inhibition as a promising therapeutic strategy for DKD treatment.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1767802","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:43:54Z","timestamp":1777351434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["sEH inhibition attenuates mtROS-mediated NLRP3 inflammasome activation by promoting mitophagy in tubular epithelial cells in diabetic kidney disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Xushun","family":"Jiang","sequence":"first","affiliation":[{"name":"Health Management Center, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Huang","sequence":"additional","affiliation":[{"name":"Health Management Center, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Nephrology, Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shi","sequence":"additional","affiliation":[{"name":"Health Management Center, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"He","sequence":"additional","affiliation":[{"name":"Health Management Center, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Du","sequence":"additional","affiliation":[{"name":"Health Management Center, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00164.2016","article-title":"The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction","volume":"311","author":"Chevalier","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0423-9","article-title":"A more tubulocentric view of diabetic kidney disease","volume":"30","author":"Zeni","year":"2017","journal-title":"J Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0329","article-title":"Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease","volume":"46","author":"Jung","year":"2022","journal-title":"Diabetes Metab J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1848971","article-title":"Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy","volume":"17","author":"Lin","year":"2021","journal-title":"Autophagy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212476","article-title":"The role of NLRP3 inflammasome in lupus nephritis","volume":"22","author":"Oliveira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.06.010","article-title":"Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease","volume":"102","author":"Shahzad","year":"2022","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1342350","article-title":"Activation of the Nrf2\/ARE signaling pathway ameliorates hyperlipidemia-induced renal tubular epithelial cell injury by inhibiting mtROS-mediated NLRP3 inflammasome activation","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","article-title":"Soluble epoxide hydrolase: gene structure, expression and deletion","volume":"526","author":"Harris","year":"2013","journal-title":"Gene"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: A potential target for metabolic diseases","volume":"8","author":"He","year":"2016","journal-title":"J Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/acs.jmedchem.0c01507","article-title":"Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products","volume":"64","author":"Sun","year":"2021","journal-title":"J Med Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.123.322619","article-title":"Epoxyeicosatrienoic acids prevent cardiac dysfunction in viral myocarditis via interferon type I signaling","volume":"133","author":"Zhou","year":"2023","journal-title":"Circ Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910629","article-title":"Soluble epoxide hydrolase inhibition attenuates proteinuria by alleviating renal inflammation and podocyte injuries in adriamycin-induced nephropathy","volume":"25","author":"Niu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154380","article-title":"Total flavonoids of Inula japonica alleviated the inflammatory response and oxidative stress in LPS-induced acute lung injury via inhibiting the sEH activity: Insights from lipid metabolomics","volume":"107","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41419-020-2594-x","article-title":"Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy","volume":"11","author":"Jiang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1908706116","article-title":"The single-cell transcriptomic landscape of early human diabetic nephropathy","volume":"116","author":"Wilson","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1016\/j.celrep.2019.11.006","article-title":"Liver soluble epoxide hydrolase regulates behavioral and cellular effects of chronic stress","volume":"29","author":"Qin","year":"2019","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13410","article-title":"Regulation of the NLRP3 inflammasome by autophagy and mitophagy","volume":"329","author":"Gupta","year":"2025","journal-title":"Immunol Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-024-06306-1","article-title":"Targeting the NLRP3 inflammasome-IL-1\u03b2 pathway in type 2 diabetes and obesity","volume":"68","author":"Meier","year":"2025","journal-title":"Diabetologia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","article-title":"The NLRP3 inflammasome and its role in sepsis development","volume":"43","author":"Danielski","year":"2020","journal-title":"Inflammation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109941","article-title":"NLRP3 inflammasome signalling in Alzheimer\u2019s disease","volume":"252","author":"McManus","year":"2024","journal-title":"Neuropharmacology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1703560","article-title":"Targeting the NLRP3 inflammasome in kidney disease: molecular mechanisms, pathogenic roles, and emerging small-molecule therapeutics","volume":"16","author":"Luo","year":"2025","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12964-024-01728-1","article-title":"Tonabersat suppresses priming\/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease","volume":"22","author":"Cliff","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-016-0827-4","article-title":"Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance","volume":"39","author":"Yu","year":"2016","journal-title":"Arch Pharm Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312571110","article-title":"Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection","volume":"110","author":"Ichinohe","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","article-title":"Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis","volume":"16","author":"Han","year":"2018","journal-title":"Redox Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2020.102180","article-title":"Soluble epoxide hydrolase as a therapeutic target for obesity-induced disorders: roles of gut barrier function involved","volume":"162","author":"Zhang","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-010-0108-5","article-title":"Soluble epoxide hydrolase in atherosclerosis","volume":"12","author":"Wang","year":"2010","journal-title":"Curr Atheroscler Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2016.05.004","article-title":"EETs\/sEH in diabetes and obesity-induced cardiovascular diseases","volume":"125","author":"Huang","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158267","article-title":"COX-2\/sEH dual inhibitor alleviates hepatocyte senescence in NAFLD mice by restoring autophagy through Sirt1\/PI3K\/AKT\/mTOR","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7150\/thno.43108","article-title":"A COX-2\/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.12.131","article-title":"PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice","volume":"523","author":"Sun","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00930-8","article-title":"Mitophagy in human health, ageing and disease","volume":"5","author":"Picca","year":"2023","journal-title":"Nat Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01513-9","article-title":"The role of PINK1-Parkin in mitochondrial quality control","volume":"26","author":"Narendra","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1","volume":"11","author":"Xiao","year":"2017","journal-title":"Redox Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.10.009","article-title":"Mitochondrial protein TOMM7 alleviates diabetic kidney disease by regulating mitophagy via intracellular redistribution of phospholipase PLA2G6","volume":"109","author":"Wang","year":"2026","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0835-2","article-title":"Mitophagy contributes to the pathogenesis of inflammatory diseases","volume":"41","author":"Zhao","year":"2018","journal-title":"Inflammation"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103159","article-title":"SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression","volume":"72","author":"Lv","year":"2024","journal-title":"Redox Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156928","article-title":"Ciliatoside A attenuates neuroinflammation in Alzheimer\u2019s disease by activating mitophagy and inhibiting NLRP3 inflammasome activation","volume":"145","author":"Guo","year":"2025","journal-title":"Phytomedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12944-024-02263-1","article-title":"Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy","volume":"23","author":"Hu","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01886","article-title":"Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative","volume":"64","author":"Hammock","year":"2021","journal-title":"J Med Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-021-01398-8","article-title":"A double-blind, randomized, placebo-controlled trial of soluble epoxide hydrolase inhibition in patients with aneurysmal subarachnoid hemorrhage","volume":"36","author":"Martini","year":"2022","journal-title":"Neurocrit Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1767802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:43:59Z","timestamp":1777351439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1767802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2026.1767802"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1767802","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1767802"}}